Skip to main content

Table 3 Adverse events

From: Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial

Adverse events

N = 3

Sleeplessness with psychological disorders after 10 days of treatment for which deblinding of treatment was broken

1

Restlessness for which patient stopped treatment after 8 days

1

Stomach irritation for which omeprazole was needed, full treatment compliance

1